Representatives of KidneyCan and the AUA (American Urological Association) visited with the Kidney Cancer Research Program staff at Ft. Detrick, Maryland recently
Our President, Bryan Lewis represented KidneyCan at the 9th global summit for Kidney Cancer in Lisbon, Portugal. IKCC (International Kidney Cancer
The treatment part of this Phase 1 clinical trial for kidney cancer is over, now we're in the watching and waiting phase.
NIH researchers are exploring ways to help T-cells used for immunotherapy not only last longer but replicate and grow. Read about this
My husband is participating in a first in human or Phase 1 clinical trial. This trial is for kidney cancer and
Bryan Lewis, Ralph & Brenda Knapp, founders of KidneyCan had the pleasure of sitting down with
KidneyCan submitted a letter to the Congressional leadership of the House Appropriations Committee in early March. The letter was hand delivered
My husband Ralph is in his 4th day of a First In Human clinical trial at NIH. He is patient #3.
My husband has a chance for a cure. He is patient #3 in a first in human clinical trial for kidney
KidneyCAN sponsored the Kidney Cancer Advocacy Day in DC and was attended by more than 20 kidney cancer patient advocates from